EconStat made several presentations at the recent ISPOR 2018 Congress.    “Vascular Access-Specific HRQOL Impacts Among Hemodialysis Patients: The Hemodialysis Access-Related QOL (HARQ) Project Focus Group Results Results” highlighted results from qualitative research to develop a novel quality of life questionnaire for dialysis patients.  Two presentations focused on economic analyses of a novel vasopressor used in the intensive care unit; the cost-effectiveness analysis showed Giapreza to be a highly cost-effective treatment for severe distributive shock in the ICU.